MA32618B1 - Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives - Google Patents

Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives

Info

Publication number
MA32618B1
MA32618B1 MA33679A MA33679A MA32618B1 MA 32618 B1 MA32618 B1 MA 32618B1 MA 33679 A MA33679 A MA 33679A MA 33679 A MA33679 A MA 33679A MA 32618 B1 MA32618 B1 MA 32618B1
Authority
MA
Morocco
Prior art keywords
octahydro
indole
methyl ester
acid methyl
oxo
Prior art date
Application number
MA33679A
Other languages
Arabic (ar)
English (en)
Inventor
Ernst Kuesters
Murat Acemoglu
Philipp Lustenberger
Gottfried Sedelmeier
Beat Schmidt
Gerhard Penn
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41278189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32618(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA32618B1 publication Critical patent/MA32618B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention porte sur un procédé de production d'ester méthylique d'acide (3ar, 4s,7ar)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylique (i), d'énantiomères d'ester (2-chloroéthyl) (3-oxocyclohexyl)-alkylique de l'acide carbamique (ii)et d'énantiomères de 1-carbalcoxy-4-cétoperhydroindole (iii).
MA33679A 2008-08-12 2011-03-07 Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives MA32618B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8815608P 2008-08-12 2008-08-12
PCT/EP2009/060351 WO2010018154A1 (fr) 2008-08-12 2009-08-10 Procédés de préparation d'ester méthylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses dérivés

Publications (1)

Publication Number Publication Date
MA32618B1 true MA32618B1 (fr) 2011-09-01

Family

ID=41278189

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33679A MA32618B1 (fr) 2008-08-12 2011-03-07 Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives

Country Status (22)

Country Link
US (1) US8084487B2 (fr)
EP (1) EP2315748B1 (fr)
JP (1) JP5468608B2 (fr)
KR (1) KR101673634B1 (fr)
CN (1) CN102119151A (fr)
AU (1) AU2009281218B2 (fr)
BR (1) BRPI0917492A8 (fr)
CA (1) CA2732095C (fr)
CL (1) CL2011000296A1 (fr)
CO (1) CO6341608A2 (fr)
EC (1) ECSP11010883A (fr)
ES (1) ES2547269T3 (fr)
HK (1) HK1155733A1 (fr)
IL (1) IL210835A (fr)
MA (1) MA32618B1 (fr)
MX (1) MX2011001664A (fr)
MY (1) MY151183A (fr)
NZ (1) NZ590753A (fr)
PE (1) PE20110415A1 (fr)
RU (1) RU2513856C2 (fr)
WO (1) WO2010018154A1 (fr)
ZA (1) ZA201100558B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012084873A1 (fr) 2010-12-20 2012-06-28 Novartis Ag Esters d'acides 4-(hétéro)aryl-éthynyl-octahydro-indole-1-carboxyliques
US9067881B2 (en) 2011-01-24 2015-06-30 Novartis Ag 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives
EP2650284A1 (fr) 2012-04-10 2013-10-16 Merz Pharma GmbH & Co. KGaA Dérivés hétérocycliques comme modulateurs de récepteurs du glutamate métabotropique
JP2020529975A (ja) 2017-07-31 2020-10-15 ノバルティス アーゲー コカイン使用の低減又はコカイン使用再燃の予防におけるマボグルラントの使用
CA3067688A1 (fr) 2017-07-31 2019-02-07 Novartis Ag Utilisation de mavoglurant dans la reduction de l'utilisation d'alcool ou dans la prevention de rechute dans l'utilisation d'alcool
US20220175793A1 (en) * 2019-01-29 2022-06-09 Novartis Ag The use of an mglur5 antagonist for treating opioid analgesic tolerance
CA3181961A1 (fr) 2020-07-17 2022-01-20 Novartis Ag Utilisation d'antagonistes de mglur5
US20240050408A1 (en) 2020-12-11 2024-02-15 Novartis Ag Use of mglur5 antagonists for treating amphetamine addiction
US20240082215A1 (en) 2020-12-14 2024-03-14 Novartis Ag Use of mglur5 antagonists for treating gambling disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) 2001-12-04 2002-01-23 Novartis Ag Organic compounds
GB0514296D0 (en) * 2005-07-12 2005-08-17 Novartis Ag Organic compounds
WO2008031550A2 (fr) * 2006-09-11 2008-03-20 Novartis Ag Nouvelles utilisations de récepteurs de glutamate métabotropiques
SG185293A1 (en) * 2007-10-12 2012-11-29 Novartis Ag Organic compounds
AU2009265760B2 (en) * 2008-06-30 2013-07-18 Novartis Ag Combinations comprising mGluR modulators for the treatment of parkinson's disease

Also Published As

Publication number Publication date
CN102119151A (zh) 2011-07-06
ES2547269T3 (es) 2015-10-05
NZ590753A (en) 2012-06-29
MY151183A (en) 2014-04-30
IL210835A (en) 2016-05-31
EP2315748B1 (fr) 2015-06-24
AU2009281218B2 (en) 2013-05-16
IL210835A0 (en) 2011-04-28
EP2315748A1 (fr) 2011-05-04
AU2009281218A1 (en) 2010-02-18
JP2011530566A (ja) 2011-12-22
KR20110042222A (ko) 2011-04-25
CO6341608A2 (es) 2011-11-21
WO2010018154A1 (fr) 2010-02-18
US8084487B2 (en) 2011-12-27
JP5468608B2 (ja) 2014-04-09
ZA201100558B (en) 2011-10-26
CA2732095C (fr) 2017-04-25
US20110144352A1 (en) 2011-06-16
PE20110415A1 (es) 2011-07-04
CA2732095A1 (fr) 2010-02-18
RU2011108663A (ru) 2012-09-20
BRPI0917492A8 (pt) 2016-07-05
HK1155733A1 (en) 2012-05-25
RU2513856C2 (ru) 2014-04-20
BRPI0917492A2 (pt) 2015-08-04
KR101673634B1 (ko) 2016-11-07
MX2011001664A (es) 2011-03-25
CL2011000296A1 (es) 2011-11-04
ECSP11010883A (es) 2011-04-29

Similar Documents

Publication Publication Date Title
MA32618B1 (fr) Procedes de preparation d'ester methylique d'acide 4-oxo-octahydro-indole-1-carbocylique et de ses derives
ATE502001T1 (de) Herstellung von essigsäure
EA200870262A1 (ru) Способ получения оптических активных хиральных аминов
FR2884818B1 (fr) Procede de preparation d'acide acrylique a partir de glycerol
FR2897059B1 (fr) Procede de preparation d'acide acrylique
EA201070700A1 (ru) Способы получения циклоалкилкарбоксамидопиридинбензойных кислот
FR2909999B1 (fr) Procede de preparation d'acide acrylique a partir de glycerol
MA32255B1 (fr) Procede pour la preparation de triamides a partir d'ammmoniac et d'amidodichlorures
ATE517190T1 (de) Verfahren zur fermentativen herstellung von 1,5- diaminopentan
ITMI20081164A1 (it) Processo per la produzione di esteri dell'acido levulinico da biomasse
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
FR2884817B1 (fr) Procede de preparation d'acide acrylique a partir de glycerol
DE602004008183D1 (de) Verfahren zur Herstellung von L-Cystein unter Verwendung eines zur Gattung Escherichia gehörenden Bakteriums
ATE440816T1 (de) Neues verfahren zur synthese substituierter alpha-aminoindanderivate
CL2012000560A1 (es) Procedimiento de preparacion del compuesto intermediario acido 3-oxo-tetrahidrotiofeno-2-carboxilico, utiles en la preparacion de dihidrotienopirimidinas (divisional de la solicitud 3095-08).
FR2871341B1 (fr) Procede de production de jeunes plants et/ou de micro pieds meres de plantes ornementales herbacees.
EP2597461A3 (fr) Procédé de mesure directe de multiples biodégradabilités
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
IL153561A0 (en) 4-alkoxy cyclohexane-1-amino carboxylic acid esters and method for the production thereof
EA201300440A1 (ru) Способ получения (3s,3s') 4,4'-дисульфандиилбис(3-аминобутан-1-сульфокислоты)
MA33596B1 (fr) Procédé photochimique pour la production d'artémisinine
MA28704B1 (fr) Procede de production d'acide phosphorique
DE602005021461D1 (de) Verfahren zur herstellung von cabergolin
ATE459723T1 (de) Verfahren zur herstellung von (4s)-3,4-dihydroxy- 2,6,6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase
EA200801400A1 (ru) Новые производные индолизина, способ их получения и терапевтические композиции на их основе